BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24474646)

  • 1. Predictive accuracy of first post-treatment PET/CT in HPV-related oropharyngeal squamous cell carcinoma.
    Koshkareva Y; Branstetter BF; Gaughan JP; Ferris RL
    Laryngoscope; 2014 Aug; 124(8):1843-7. PubMed ID: 24474646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
    Zhang I; Branstetter BF; Beswick DM; Maxwell JH; Gooding WE; Ferris RL
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
    Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
    Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
    Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
    Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttreatment surveillance PET/CT for HPV-associated oropharyngeal cancer.
    Corpman DW; Masroor F; Carpenter DM; Nayak S; Gurushanthaiah D; Wang KH
    Head Neck; 2019 Feb; 41(2):456-462. PubMed ID: 30549345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
    Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
    Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
    Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
    J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
    Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
    Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
    Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma.
    Clark J; Jeffery CC; Zhang H; Cooper T; O'Connell DA; Harris J; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):37. PubMed ID: 26374294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.
    Subramaniam RM; Alluri KC; Tahari AK; Aygun N; Quon H
    J Nucl Med; 2014 Mar; 55(3):431-8. PubMed ID: 24408893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers.
    Huang YT; Ravi Kumar AS; Bhuta S
    Nucl Med Commun; 2015 Jan; 36(1):16-20. PubMed ID: 25340950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of PET-CT in Newly Diagnosed HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Lee J; Davis SJ; Amin SN; Rohde SL; Kim YJ
    Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1133-1139. PubMed ID: 36453776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer.
    McDermott M; Hughes M; Rath T; Johnson JT; Heron DE; Kubicek GJ; Kim SW; Ferris RL; Duvvuri U; Ohr JP; Branstetter BF
    AJNR Am J Neuroradiol; 2013 Aug; 34(8):1632-6. PubMed ID: 23639557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.